🎄🌟 🎉 Wishing our readers a Merry Christmas and a Happy New Year filled with new possibilities! 🎄🌟 🎉
Teva to uphold Copaxone patent until May 2015
Generics | News | By BioSpectrum Bureau | 0 Comment | 31 Jul, 2013
Singapore: Israel-based Teva Pharmaceuticals has recieved favourable response in England and Wales regarding the validit...Read more
Pricing revision to cost Indian pharma $160 mn
Generics | Analysis | By BioSpectrum Bureau | 2 Comment | 25 Jun, 2013
Mumbai: The pharmaceutical industry will be widely impacted after India's National Pharmaceutical Pricing Authority (NPP...Read more
US antidepressant market slides down by 4%: report
Generics | Analysis | By BioSpectrum Bureau | 2 Comment | 14 Oct, 2013
Singapore: Antidepressant market in US, that peaked at USD12 billion in 2008, has lost USD2.6 billion due to expired pat...Read more
Australia's Starpharma develops Zika-proof condoms for athletes ahead of Rio Olympics
Generics | News | By BioSpectrum Bureau | 0 Comment | 17 May, 2016
Australia's Starpharma Holdings Ltd and Ansell Limited have announced that the Australian Olympic team will be provided ...Read more
Celgene settles litigation with India's Natco
Generics | News | By BioSpectrum Bureau | 0 Comment | 28 Dec, 2015
Singapore: US based Celgene has settled the litigation with India's Natco Pharma, Natco's US partner, Arrow Internationa...Read more
Self monitoring diabetes market to reach $358 mn
Generics | Analysis | By BioSpectrum Bureau | 3 Comment | 23 Jul, 2013
Singapore: Three quarters of the population of China and India are diabetic. This translates to a patient pool of nearly...Read more
Do India's bad quality drugs end up in Africa?
Generics | News | By BioSpectrum Bureau | 0 Comment | 18 Sep, 2014
Singapore: According to a research conducted by the National Bureau of Economic Research, some generic drugs sent from I...Read more
Will Japan be able to reduce its generic drug prices?
Generics | Analysis | By BioSpectrum Bureau | 2 Comment | 21 May, 2013
The Japanese pharmaceutical market is the second largest pharma market in the world following on the close heels of the ...Read more
Daiichi Sankyo to commercialize AstraZeneca's nasal influenza vaccine in Japan
Generics | News | By BioSpectrum Bureau | 0 Comment | 02 Sep, 2015
The global biologics research and development arm of AstraZeneca, MedImmune LLC, has entered into an exclusive license a...Read more
Mylan signs a settlement agreement with OSI Pharma
Generics | News | By BioSpectrum Bureau | 0 Comment | 25 Jul, 2013
Singapore: US generics major Mylan has entered into a settlement agreement with OSI Pharmaceuticals, a subsidiary of Jap...Read more
India bans pain killer 36 years after the US did so
Generics | News | By BioSpectrum Bureau | 0 Comment | 28 Jun, 2013
New Delhi: The Indian health ministry has banned the sale of three medicines after learning about the health risks assoc...Read more
Beximco Pharma enters EU market
Generics | News | By BioSpectrum Bureau | 0 Comment | 14 Mar, 2013
Singapore: Beximco Pharmaceuticals, a manufacturer of generic pharmaceutical products and active pharmaceutical ingredie...Read more
Glenmark's new generic gets FDA nod
Generics | News | By BioSpectrum Bureau | 0 Comment | 21 Aug, 2015
Singapore: Glenmark Pharmaceuticals(Glenmark) has been granted final approval by the United States Food & Drug Admin...Read more
Amneal pharma to acquire Actavis Australia's generic business
Generics | News | By BioSpectrum Bureau | 0 Comment | 02 Apr, 2015
Singapore: US-based Amneal pharmaceuticals announced the acquisition of Actavis pharmaceuticals' generic business in Aus...Read more
ANI pharma, IDT Australia to commercialize US generic drugs
Generics | News | By BioSpectrum Bureau | 0 Comment | 18 Aug, 2015
Singapore: ANI Pharmaceuticals, a global specialty pharmaceutical company recently announced collaboration with IDT Aust...Read more
Brickell Biotech-Kaken Pharma to co-develop dermatology drug
Generics | News | By BioSpectrum Bureau | 0 Comment | 05 Apr, 2015
Brickell Biotech Inc., a US-based clinical-stage pharmaceutical company has signed an exclusive license and development ...Read more
Lupin scouts for acquisitions across the world
Generics | News | By BioSpectrum Bureau | 0 Comment | 09 Jul, 2013
Singapore: Indian drug major Lupin Pharmaceuticals is set to expand its global footprint by scouting for acquisitions ac...Read more
US rheumatoid arthritis market to reach $9.3 bn by 2020'
Generics | Analysis | By BioSpectrum Bureau | 3 Comment | 02 Apr, 2015
Singapore: US treatment market for rheumatoid arthritis (RA) is set to increase in value from $6.4 billion in 2013 to $9...Read more